Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARITY: Prophylactic Antibiotic Regimens in Tumor Surgery
NCT01479283Phase 3Completed
- Sponsor
- McMaster University
- Start
- Jan 2013
- Primary completion
- Mar 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 12
01
Overview
A Phase 3 trial of cefazolin in surgical site infection (SSI), sponsored by McMaster University. Started Jan 2013; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01479283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479283.